This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...
MedPage Today on MSN
Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study
PHOENIX -- Use of tirzepatide (Mounjaro, Zepbound) was associated with significantly lower risks of death, hospitalization, ...
Both medications have similar side effects, such as stomach issues like diarrhea, nausea, and bloating. However, metformin’s ...
GLP-1 drugs like Mounjaro, which were created to help type 2 diabetes patients and sometimes manage weight loss, actually ...
Americans are getting slimmer; Gallup says the obesity rate has decreased along with increased use of weight loss drugs such ...
16don MSNOpinion
Ozempic for All
Ensuring GLP-1s are covered by Medicaid in all states would save lives—and not be as costly as some people fear.
Health Canada on Tuesday approved Novo Nordisk's (NYSE:NVO) Ozempic (semaglutide) to reduce the risk of kidney disease and cardiovascular deaths in adults with type 2 diabetes. The approval makes ...
A new study in mice shows that intermittent fasting and calorie restriction may be the key to living longer. Jennifer Stern ...
Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results